Edition:
United States

Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

114.00GBp
7:41am EDT
Change (% chg)

1.50 (+1.33%)
Prev Close
112.50
Open
112.50
Day's High
114.00
Day's Low
114.00
Volume
470
Avg. Vol
3,651
52-wk High
255.00
52-wk Low
86.00

AKR.L

Chart for AKR.L

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)
No analyst recommendations are available for AKR.L.

Overall

Beta: 1.53
Market Cap(Mil.): £9.92
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  AKR.L Industry Sector
P/E (TTM): -- 139.31 17.29
EPS (TTM): -0.40 -- --
ROI: -57.91 2.29 -5.84
ROE: -57.91 0.06 -5.23

BRIEF-Akers Biosciences reports earnings for fiscal year 2016

* Akers Biosciences - Expect 2017 to be characterized by further growth in flagship PIFA Heparin PF/4 rapid assay product line, sales of rapid cholesterol test Source text for Eikon: Further company coverage:

Apr 11 2017

BRIEF-Akers Biosciences to commercialize heparin PF4 rapid test in Puerto Rico

* Akers Biosciences to commercialize heparin PF4 rapid test in Puerto Rico Source text for Eikon: Further company coverage:

Apr 10 2017

BRIEF-Empery Asset Management reports 8.45 pct passive stake in Akers Biosciences

* Empery Asset Management LP reports 8.45 percent passive stake in Akers Biosciences Inc, as of March 30, 2017 - sec filing Source text - http://bit.ly/2nTrng1 Further company coverage:

Apr 07 2017

BRIEF-Akers Biosciences files for non-timely 10-K - SEC filing

* Akers Biosciences Inc files for non-timely 10-K - SEC filing

Mar 31 2017

BRIEF-Akers Biosciences announces a $2 million private placement

* Akers Biosciences Inc - Akers Bio will issue 1.4 million shares at a price of $1.40 per share Source text for Eikon: Further company coverage:

Mar 30 2017

BRIEF-Akers Biosciences begins selling rapid cholesterol test

* Akers Biosciences begins selling rapid cholesterol test through distribution agreement with first check Source text for Eikon: Further company coverage:

Mar 28 2017

BRIEF-Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge

* US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device

Feb 16 2017

BRIEF-Akers Biosciences prices 1.6 mln share offering at $1.20 per share

* Akers Biosciences announces pricing of public offering of 1,667,000 shares and 833,500 warrants

Jan 09 2017

More From Around the Web

Earnings vs. Estimates